InsiderTrades.com logo
Download Our Tesla Ebook For Free
From DTI   |   Ad
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
To claim your copy free of charge simply follow this link.
William E. lv Delaney net worth and biography
  • Phone
  • Email
  • Website

William Delaney Biography and Net Worth

Insider of Assembly Biosciences
William Delaney, PhD joined Assembly as Chief Scientific Officer, Virology in May 2020. Prior to joining Assembly, he most recently served as Executive Director, Biology at Gilead. During his 20-year career at the company, he headed the Viral Hepatitis & Herpes Discovery Biology Groups and served as the Research Therapeutic Area Head for HBV. He began his career as a Research Scientist, Clinical Virology at Gilead and later transitioned into Drug Discovery where he held positions of increasing responsibility. Over the course of his career, he has contributed to the development of several marketed products, including Hepsera®, Viread®, and Vemlidy® for HBV and Sovaldi®, Harvoni®, Epclusa®, and Vosevi® for HCV. He earned a BS in Biotechnology from the University of Delaware and a PhD in Cell and Molecular Biology from the Penn State College of Medicine. In addition, he was a Postdoctoral Fellow at the Victorian Infectious Diseases Reference Laboratory (VIDRL), Department of Research & Molecular Development.

What is William E. lv Delaney's net worth?

The estimated net worth of William E. lv Delaney is at least $94,883.20 as of May 31st, 2022. Dr. Delaney owns 6,368 shares of Assembly Biosciences stock worth more than $94,883 as of November 21st. This net worth approximation does not reflect any other assets that Dr. Delaney may own. Additionally, Dr. Delaney receives a salary of $723,240.00 as Insider at Assembly Biosciences. Learn More about William E. lv Delaney's net worth.

How old is William E. lv Delaney?

Dr. Delaney is currently 52 years old. There are 3 older executives and no younger executives at Assembly Biosciences. The oldest executive at Assembly Biosciences is Mr. Thomas E. Rollins, Executive Officer, who is 68 years old. Learn More on William E. lv Delaney's age.

What is William E. lv Delaney's salary?

As the Insider of Assembly Biosciences, Inc., Dr. Delaney earns $723,240.00 per year. The highest earning executive at Assembly Biosciences is Mr. Jason A. Okazaki, CEO, President & Director, who commands a salary of $1,070,000.00 per year. Learn More on William E. lv Delaney's salary.

How do I contact William E. lv Delaney?

The corporate mailing address for Dr. Delaney and other Assembly Biosciences executives is 331 OYSTER POINT BOULEVARD FOURTH FLOOR, SOUTH SAN FRANCISCO CA, 94080. Assembly Biosciences can also be reached via phone at (833) 509-4583 and via email at [email protected]. Learn More on William E. lv Delaney's contact information.

Has William E. lv Delaney been buying or selling shares of Assembly Biosciences?

William E. lv Delaney has not been actively trading shares of Assembly Biosciences in the last ninety days. Learn More on William E. lv Delaney's trading history.

Who are Assembly Biosciences' active insiders?

Assembly Biosciences' insider roster includes William Delaney (Insider), John McHutchison (CEO), and Timothy Springer (Director). Learn More on Assembly Biosciences' active insiders.

Are insiders buying or selling shares of Assembly Biosciences?

During the last twelve months, Assembly Biosciences insiders bought shares 4 times. They purchased a total of 43,999 shares worth more than $491,421.38. During the last twelve months, insiders at the biopharmaceutical company sold shares 12 times. They sold a total of 7,974 shares worth more than $108,873.30. The most recent insider tranaction occured on November, 18th when insider Nicole S White sold 40 shares worth more than $651.60. Insiders at Assembly Biosciences own 5.1% of the company. Learn More about insider trades at Assembly Biosciences.

Information on this page was last updated on 11/18/2024.

William E. lv Delaney Insider Trading History at Assembly Biosciences

See Full Table

William E. lv Delaney Buying and Selling Activity at Assembly Biosciences

This chart shows William E. Iv Delaney's buying and selling at Assembly Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Assembly Biosciences Company Overview

Assembly Biosciences logo
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $14.90
Low: $13.41
High: $15.36

50 Day Range

MA: $16.64
Low: $14.42
High: $19.43

2 Week Range

Now: $14.90
Low: $7.69
High: $19.93

Volume

46,958 shs

Average Volume

23,645 shs

Market Capitalization

$94.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58
Download Our Tesla Ebook For Free
From DTI   |   Ad
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
To claim your copy free of charge simply follow this link.